-
Tribune Publishing (TPUB) Calls Gannett's (GCI) Letter to Shareholders 'Misleading'
-
Tribune Publishing Confirms Receipt of Revised Proposal from Gannett
-
Tribune Publishing (TPUB) Adopts 'Poison Pill' Provision
-
Tribune Publishing Adopts Shareholder Rights Plan
-
Tribune Publishing (TPUB) Rejects $12.25/Share Proposal from Gannett (GCI)
-
Tribune Publishing’s Board Unanimously Rejects Gannett’s Unsolicited Proposal
-
Tribune Publishing (TPUB) Affirms Receipt of Takeover Proposal from Gannett (GCI); Will Review
-
Tribune Publishing Confirms Receipt of Unsolicited Proposal from Gannett
-
New York Times (NYT) Lower as Lazard Capital Downgrades to 'Sell'
-
Gannett (GCI) Shares Fall on Lazard Downgrade; Still Up Double-Digits Since November '11
-
Lazard Capital Downgrades Gannett (GCI) to Neutral
-
Morning Movers 12/05: (SFSF) (ATHX) (AFFY) (TLEO) Higher; (GLUU) (VISN) Lower
-
Lazard Capital Upgrades Gannett (GCI) to Buy
-
Notable Analyst Rating Changes 04/07: (HERO) (ELN) (CRM) Upgraded; (MDRX) (CNL) (SSW) Downgraded
-
Lazard Capital Starts Gannett (GCI) at Hold
-
Notable Analyst Rating Changes 12/23: SLB, GLW, GCI, NYT, SNDK, THC Upgraded; XOM, ALGT, POT, CTAS Downgraded
-
Unusual 11 Mid-Day Movers 9/29: ASTC, LEE, SNR, NVGN Higher; SQNM, RCON, QBAK, SLTM Lower

